Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction

被引:33
|
作者
Malik, Awais [1 ,2 ,3 ]
Gill, Gauravpal S. [1 ]
Lodhi, Fahad K. [1 ,2 ]
Tummala, Lakshmi S. [1 ,2 ,5 ]
Singh, Steven N. [1 ,2 ,4 ]
Morgan, Charity J. [1 ,4 ]
Allman, Richard M. [5 ]
Fonarow, Gregg C. [6 ]
Ahmed, Ali [1 ,2 ,5 ]
机构
[1] Vet Affairs Med Ctr, 50 Irving St NW, Washington, DC 20422 USA
[2] Georgetown Univ, Washington, DC 20057 USA
[3] MedStar Washington Hosp Ctr, Washington, DC USA
[4] Univ Alabama Birmingham, Birmingham, AL USA
[5] George Washington Univ, Washington, DC 20052 USA
[6] Univ Calif Los Angeles, Los Angeles, CA 90024 USA
来源
AMERICAN JOURNAL OF MEDICINE | 2020年 / 133卷 / 01期
基金
美国国家卫生研究院;
关键词
Heart failure; Mortality; Preserved ejection fraction; Prior hospitalization; Readmission; SUBSEQUENT MORTALITY; PREDICT MORTALITY; PROPENSITY SCORE; OPTIMIZE-HF; POPULATION; IRBESARTAN; DIURETICS; RATIONALE; DEATH;
D O I
10.1016/j.amjmed.2019.06.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: A prior hospitalization resulting from heart failure is associated with poor outcomes in ambulatory patients with heart failure. Less is known about this association in hospitalized patients with heart failure and whether it varies by ejection fraction. METHODS: Of the 25,345 hospitalized patients in the Medicare-linked OPTIMIZE-HF registry, 22,491 had known heart failure, of whom 7648 and 9558 had heart failure with preserved (>= 50%) and reduced (<= 40%) ejection fraction (HFpEF and HFrEF), respectively. Overall, 927 and 1862 patients with HFpEF and HFrEF had hospitalizations for heart failure during the 6 months before the index hospitalization, respectively. Using propensity scores for prior heart failure hospitalization, we assembled two matched cohorts of 924 pairs and 1844 pairs of patients with HFpEF and HFrEF, respectively, each balanced for 58 baseline characteristics. Cox regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for outcomes during 6 years of follow-up. RESULTS: Among 1848 matched patients with HFpEF, HRs (95% CIs) for all-cause mortality, all-cause readmission, and heart failure readmission were 1.35 (1.21-1.50; P < 0.001), 1.34 (1.21-1.47; P < 0.001), and 1.90 (1.67-2.16; P <0.001), respectively. Respective HRs (95% CIs) in 3688 matched patients with HFrEF were 1.17 (1.09-1.26; P <0.001), 1.32 (1.23-1.41; P <0.001), and 1.48 (1.37-1.61; P <0.001). CONCLUSIONS: Among hospitalized patients with heart failure, a previous hospitalization for heart failure is associated with higher risks of mortality and readmission in both HFpEF and HFrEF. The relative risks of death and heart failure readmission appear to be higher in HFpEF than in HFrEF. Published by Elsevier Inc.
引用
收藏
页码:84 / 94
页数:11
相关论文
共 50 条
  • [1] Heart failure hospitalization in patients with reduced ejection fraction in a heart failure clinic
    Daniel Seabra, D.
    Oliveira, I.
    Neto, A.
    Andrade, A.
    Azevedo, J.
    Pinto, P.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 380 - 380
  • [2] Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction
    Kristensen, Soren L.
    Jhund, Pardeep S.
    Kober, Lars
    Preiss, David
    Kjekshus, John
    McKelvie, Robert S.
    Zile, Michael R.
    Anand, Inder S.
    Wikstrand, John
    Wedel, Hans
    Komajda, Michel
    Carson, Peter E.
    Cleland, John G. F.
    McMurray, John J. V.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (02) : 169 - 176
  • [3] Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
    Poppe, Katrina K.
    Doughty, Robert N.
    [J]. HEART FAILURE CLINICS, 2014, 10 (03) : 503 - +
  • [4] Prior Heart Failure Hospitalization, Clinical Outcomes, and Effect of Sacubitril/Valsartan Compared With Valsartan in Heart Failure With Preserved Ejection Fraction
    Vaduganathan, Muthiah
    Claggett, Brian
    Anker, Stefan D.
    Perrone, Sergio V., Sr.
    Janssens, Stefan P.
    Milicic, Davor
    Arango, Juan L.
    Packer, Milton
    McMurray, John J.
    Solomon, Scott
    [J]. CIRCULATION, 2019, 140 (25) : E995 - E996
  • [5] Heart Failure Preserved Ejection Fraction Patients Benefit From Heart Failure Reduced Ejection Fraction Guidelines
    Steahr, Gregg
    Kelly, Linda
    Moore, Meredith
    Hott, Brenda
    [J]. JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S73 - S74
  • [6] Mortality and Readmissions in Patients With Heart Failure With Preserved Ejection Fraction versus Heart Failure With Reduced Ejection Fraction
    Carcora, Yaser
    Gravely, Amy
    Tholakanahalli, Venkatakrishna N.
    Adabag, Selcuk
    [J]. CIRCULATION, 2021, 144
  • [7] Statins Beneficial for Heart Failure With Preserved Ejection Fraction But Not Heart Failure With Reduced Ejection Fraction?
    Ohte, Nobuyuki
    Little, William C.
    [J]. CIRCULATION JOURNAL, 2015, 79 (03) : 508 - 509
  • [8] Difference in pattern of mortality between heart failure with reduced ejection fraction and heart failure with preserved ejection fraction after hospitalization for acute decompensated heart failure
    Nakashima, M. Mitsutaka
    Sakuragi, S.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 424 - 424
  • [9] Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction
    Kajimoto, Katsuya
    Minami, Yuichiro
    Sato, Naoki
    Kasanuki, Hiroshi
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (12): : 1881 - 1887
  • [10] Duration of heart failure and outcomes in patients with heart failure and reduced ejection fraction
    Tomer, M. Meenakshi
    Gannuscio, J.
    Valentova, M.
    Fonarow, G.
    Adamopoulos, C.
    Kanonidis, I.
    Deedwania, P.
    Aronow, W.
    Anker, S.
    Ahmed, A.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 196 - 197